Elizabeth Daloisio

Long-Term Safety and Efficacy of Esketamine Nasal Spray in Black and/or African American Adults With Treatment-Resistant Depression: A Subgroup Analysis of the SUSTAIN-3 Study

Abstract: Purpose: This subgroup analysis of SUSTAIN-3 (NCT02782104), an ongoing open-label extension study of esketamine nasal spray (ESK), assessed long-term safety and efficacy of flex...

Elizabeth Daloisio ;

Susan Lakey Kevo ;

01/19/2023

Real-World Safety Profile of Esketamine Nasal Spray During the First 12 Treatment Sessions: An Analysis at 34 Months After Approval

Abstract: Purpose: To examine real-world esketamine nasal spray (ESK) treatment-emergent adverse events (TEAEs) of interest (i.e., sedation, dissociation, increased blood pressure [BP]) a...

Brianne Brown , PsyD;

Elizabeth Daloisio ;

01/19/2023

Relapse in Adequately Versus Not Adequately Treated Black or African American Patients With Schizophrenia Transitioned to Paliperidone Palmitate Once-Every-3-Months Injection: A Retrospective Analysis

Abstract: Purpose: Paliperidone palmitate once-every-3-months (PP3M), a long-acting injectable antipsychotic, is indicated for adults with schizophrenia adequately treated (AT) with palip...

Karen C. Johnston , MD, MSc;

Elizabeth Daloisio ;

01/19/2023

Relapse in Adequately Versus Not Adequately Treated Female Patients With Schizophrenia Who Transitioned to Once-Every-3-Months Paliperidone Palmitate Injections: A Retrospective Claims Database Study

Abstract: Purpose: Paliperidone palmitate once-every-3-months (PP3M) is a long-acting injectable antipsychotic indicated for adults with schizophrenia adequately treated (AT) with once-mo...

Elizabeth Daloisio ;

Jennifer Kern Sliwa , PharmD, BCPP;

01/19/2023

Efficacy and Safety of Early Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia: A Duration of Illness Meta-Analysis

Abstract: Background: Although long-acting injectable antipsychotics (LAIs) are often reserved for patients with chronic schizophrenia, emerging evidence suggests that LAIs may reduce the...

Elizabeth Daloisio ;

Jennifer Kern Sliwa , PharmD, BCPP;

01/19/2023